PCI looks to Boston for growth; 3M signs on to help Mylan make generic Advair;

> Contract drugmaker PCI Synthesis is increasingly looking to its native Boston for partnership deals, tapping the area's fast-growing biotech ecosystem to flesh out its client base. Story

> 3M ($MMM) has signed on to help Mylan ($MYL) manufacture the delivery device key to its generic version of GlaxoSmithKline's ($GSK) blockbuster COPD treatment Advair. News

Suggested Articles

WIRB-Copernicus launched a product aimed at upping the efficiency of clinical research operators at institutions and independent research sites.

Celgene is paying Exscientia $25 million up front in a three-year discovery deal for three programs in oncology and autoimmunity.

Ovation.io reeled in $5 million in series A funding that it plans to use to accelerate lab deployment and expand other features.